PXMD PaxMedica, Inc.

4,421

$0.90

$0.02

(2.17%)

Today

Watchers	4,421
52-Wk Low	$0.7979
52-Wk High	$69.19

Volume (M)	1,145.00
52-Wk High	$69.19
52-Wk Low	$0.7979

Fundamentals

PaxMedica Announces Closing of $7.0 Million Public OfferingAccesswire • 12 days ago

TARRYTOWN, NY / ACCESSWIRE / November 22, 2023 / PaxMedica, Inc. (NASDAQ:PXMD) ('PaxMedica' or the 'Company'), a biopharmaceutical company focused on advancing treatments for neurological disorders...

Share to Feed

Why Is PaxMedica (PXMD) Stock Down 40% Today?InvestorPlace • 14 days ago

InvestorPlace - Stock Market News, Stock Advice & Trading Tips PXMD stock is sinking lower after the company announced a $7 million public offering of over 5 million shares and warrants. The post Why...

Crude Oil Gains Over 2%; PaxMedica Shares PlungeBenzinga • 14 days ago

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining over 100 points on Monday. The Dow traded up 0.34% to 35,064.42 while the NASDAQ rose 0.80% to 14,238.67. The S&P...

PaxMedica Announces Pricing of $7.0 Million Public OfferingAccesswire • 14 days ago

TARRYTOWN, NY / ACCESSWIRE / November 20, 2023 / PaxMedica, Inc. (NASDAQ:PXMD) ('PaxMedica' or the 'Company'), a biopharmaceutical company focused on advancing treatments for neurological disorders...

PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial DataGlobe Newswire • 17 days ago

LOS ANGELES, Nov. 17, 2023 (GLOBE NEWSWIRE) -- via IBN PaxMedica, Inc. (NASDAQ: PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announces that...

PaxMedica, Inc. Announces Third Quarter 2023 Financial Results and Business UpdateAccesswire • 19 days ago

TARRYTOWN, NY / ACCESSWIRE / November 15, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced today a comprehensive...

What's Going On With PaxMedica Stock Today?Benzinga • 20 days ago

PaxMedica, Inc. (NASDAQ: PXMD) shares are trading higher on Tuesday. The stock has been volatile over the past month. read more...

PaxMedica's Chief Medical Officer Discusses FDA Meeting Highlights on The Bell2Bell PodcastGlobe Newswire • 25 days ago

LOS ANGELES, Nov. 09, 2023 (GLOBE NEWSWIRE) -- IBN, a leading communications organization focused on linking public companies to the investment community, has unveiled the latest episode of The...

PaxMedica Announces Publication of Its Autism Spectrum Disorder Phase 2 Study Results in Peer-reviewed JournalAccesswire • 27 days ago

TARRYTOWN, NY / ACCESSWIRE / November 7, 2023 / PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, announced the publication of...

Acerus Pharmaceuticals (OTCMKTS:ASPCF) vs. PaxMedica (NASDAQ:PXMD) Head to Head SurveyZolmax • 29 days ago

Acerus Pharmaceuticals (OTCMKTS:ASPCF Get Free Report) and PaxMedica (NASDAQ:PXMD Get Free Report) are both small-cap medical companies, but which is the better investment? We will...